Research progress on the role of kallikrein 8 in neurological diseases

doi:10.16352/j.issn.1001-6325.2023.04.0660

Abstract

Abstract: Kallikrein 8(KLK8) is closely related to the central nervous system and is involved in the pathological processes of many neurological diseases by altering inter-synaptic adhesion relationships and extracellular matrix molecules thereby modifying synaptic morphology and regulating synaptic plasticity. In this paper, we review the role and pathogenesis of KLK8 in neurological disorders such as dysthymic disorders, Alzheimer's disease, epilepsy, and multiple sclerosis with respect to its physiological properties. It is expected to provide a theoretical basis for the diagnosis and prognosis of neurological diseases and provide directions for the research of such diseases.

Key words: kallikrein 8, synaptic plasticity, dysthymic disorders, Alzheimer's disease

CLC Number:

LIU Shiyu, LIU Yujian. Research progress on the role of kallikrein 8 in neurological diseases[J]. Basic & Clinical Medicine, 2023, 43(4): 660-664.

References 24

[1]	Pampalakis G, Zingkou E, Panagiotidis C, et al. Kallikreins emerge as new regulators of viral infections[J]. Cell Mol Life Sci, 2021, 78: 6735-6744.
[2]	Di Paolo, Diamandis EP, Prassas I. The role of kalli-kreins in inflammatory skin disorders and their potential as therapeutic targets[J]. Crit Rev Clin Lab Sci, 2021, 58: 1-16.
[3]	Mella C, Figueroa CD, Otth C, et al. Involvement of Kallikrein-related peptidases in nervous system disorders[J]. Front Cell Neurosci, 2020, 14: 166.doi:10.3389/Fncel.2020.00166.
[4]	Bukowski L, Chernomorchenko AMF, Starnawska A, et al. Neuropsin in mental health[J]. J Physiol Sci, 2020, 70: 26.
[5]	Konar A, Thakur MK. Neuropsin expression correlates with dendritic marker MAP2c level in different brain regions of aging mice[J]. Mol Neurobiol, 2015, 51: 1130-1138.
[6]	Konar A, Kumar A, Maloney B, et al. A serine protease KLK8 emerges as a regulator of regulators in memory: Microtubule protein dependent neuronal morphology and PKA-CREB signaling[J]. Sci Rep, 2018, 8: 9928.doi:10.1038/s41598-018-27640-6.
[7]	He X, Wang Y, Zhou G, et al. A critical role for gammaCaMKII in decoding NMDA signaling to regulate AMPA receptors in putative inhibitory interneurons[J]. Neurosci Bull, 2022. doi:10.1007/s12264-022-00840-x.
[8]	Attwood BK, Bourgognon JM, Patel S, et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety[J]. Nature, 2011, 473: 372-375.
[9]	Nakazawa H, Suzuki Y, Ishikawa Y, et al. Impaired social discrimination behavior despite normal social approach by kallikrein-related peptidase 8 knockout mouse[J]. Neurobiol Learn Mem, 2019, 162: 47-58.
[10]	Ishikawa Y, Tamura H, Shiosaka S. Diversity of neuropsin (KLK8)-dependent synaptic associativity in the hippocampal pyramidal neuron[J]. J Physiol, 2011, 589: 3559-3573.
[11]	Yang J, Kang C, Wu C, et al. Pharmacogenetic associations of NRG1 polymorphisms with neurocognitive performance and clinical symptom response to risperidone in the untreated schizophrenia[J]. Schizophr Res, 2021, 231: 67-69.
[12]	Chang S, Bok P, Sun CP, et al. Neuropsin inactivation has protective effects against depressive-like behaviours and memory impairment induced by chronic stress[J]. PLoS Genet, 2016, 12: e1006356, doi:10.1371/journal.pgen.1006356.
[13]	Bobinska K, Mossakowska-Wojcik J, Szemraj J, et al. Human neuropsin gene in depression[J]. Psychiatr Danub, 2017, 29: 195-200.
[14]	Schramm S, Jokisch M, Jockel KH, et al. Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study[J]. Alzheimers Res Ther, 2021, 13: 202.doi:10.1186/s13195-021-00945-x.
[15]	Herring A, Kurapati NK, Krebs S, et al. Genetic knockdown of Klk8 has sex-specific multi-targeted therapeutic effects on Alzheimer's pathology in mice[J]. Neuropathol Appl Neurobiol, 2021, 47: 611-624.
[16]	Munster Y, Keyvani K, Herring A. Inhibition of excessive kallikrein-8 improves neuroplasticity in Alzheimer's disease mouse model [J]. Exp Neurol, 2020, 324: 113-115.
[17]	Keyvani K, Munster Y, Kurapati NK, et al. Higher levels of kallikrein-8 in female brain may increase the risk for Alzheimer's disease[J]. Brain Pathol, 2018, 28: 947-964.
[18]	Drucker KL, Gianinni C, Decker PA, et al. Prognostic significance of multiple kallikreins in high-grade astrocytoma[J]. BMC Cancer, 2015, 15: 565.doi:10.1186/s12885-015-1566-5.
[19]	Srinivasan S, Kryza T, Batra J, et al. Remodelling of the tumour microenvironment by the kallikrein-related peptidases[J]. Nat Rev Cancer, 2022, 22: 223-238.
[20]	Panos M, Christophi GP, Rodriguez M, et al. Differen-tial expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response[J]. Biol Chem, 2014, 395: 1063-1073.
[21]	Missault S, Peeters L, Amhaoul H, et al. Decreased levels of active uPA and KLK8 assessed by[(111)In]MICA-401 binding correlate with the seizure burden in an animal model of temporal lobe epilepsy[J]. Epilepsia, 2017, 58: 1615-1625.
[22]	Kawata M, Morikawa S, Shiosaka S, et al. Ablation of neuropsin-neuregulin 1 signaling imbalances ErbB4 inhibitory networks and disrupts hippocampal gamma oscillation[J]. Transl Psychiatry, 2017, 7: e1052, doi:10.1038/tp.2017.20.
[23]	Ray B, Sokol DK, Maloney B, et al. Finding novel distinctions between the sAPP-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue[J]. Sci Rep, 2016, 6: 26-52.
[24]	Diab A, Qi J, Shahin I, et al. NCK1 regulates amygdala activity to control context-dependent stress responses and anxiety in male mice[J]. Neuroscience, 2020, 448: 107-125.